BGA
EW icon

Battery Global Advisors’s Edwards Lifesciences EW Stock Holding History

Battery Global Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
1,434
+1,316
+1,115% +$108K 0.06% 52
2025
Q4 		$37.6K Sell
118
-1,316
-92% -$108K 0.02% 92
2025
Q3 		$112K Hold
1,434
– – 0.05% 52
2025
Q2 		$112K Hold
1,434
– – 0.06% 48
2025
Q1 		$104K Hold
1,434
– – 0.06% 47
2024
Q4 		$106K Hold
1,434
– – 0.06% 47
2024
Q3 		$94.6K Buy
+1,434
New +$104K 0.05% 49

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Battery Global Advisors's EW Position: Q1 2026 in Review

Battery Global Advisors increased its Edwards Lifesciences (EW) stake by 1,115% in Q1 2026, buying an estimated $108K and bringing the position to 1,434 shares worth $115K. The position accounts for 0.06% of the portfolio, ranked #52.

Battery Global Advisors first reported a position in EW in Q3 2024 and has held it in 7 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Battery Global Advisors held 1,434 shares of Edwards Lifesciences worth $115K as of Q1 2026.
  • Battery Global Advisors bought 1,316 Edwards Lifesciences shares in Q1 2026, an estimated $108K.
  • Edwards Lifesciences made up 0.06% of Battery Global Advisors's portfolio in Q1 2026, its #52 holding.
  • Battery Global Advisors first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Battery Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.